Novo Nordisk slashes price of Ozempic
Digest more
GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access manufacturer-sponsored savings at t
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, jumped 5% through 9:55 a.m. ET Monday on a series of positive announcements for its GLP-1 products.
As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar Mike Doustdar, the company isn't making a point to rapidly add staffers.
The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.
Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official website.
Over 1,800 lawsuits claim Ozempic caused stomach paralysis, vision loss, and more. Read what’s next in the legal fight.
Some women are complaining of 'Ozempic vulva' and GLP-1 medications can causes changes to women's private parts.